SPRIM Global Investments (SGI) is a privately held investment company established in 2008 following the global expansion of SPRIM Service business. SGI provides equity investment, debt, and royalty financing to clinical stage Biotech companies and late-stage MedTech. The investment strategy focuses on companies that can leverage SPRIM's global network and expertise across its fellow venture companies. SGI aims to build the future of health by supporting innovative solutions in the healthcare, food, and life sciences sectors. The firm provides more than just capital; it offers portfolio companies access to a global network of experts.
Preferred startup development maturity for initial funding deployment.
Biotech, MedTech, Healthcare, Food, Life Sciences
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...